Effective medicines have been developed or repurposed to treat COVID-19, but they are too often not accessible or affordable, particularly in low- and middle-income countries.

The coalition is conducting a very short survey on COVID-19 medicine availability.

Survey responses will provide a snapshot of access to inform a webinar on COVID-19 therapeutics that the coalition is planning to hold in the next few months. The survey is anonymous and can be filled out quickly, as it has only five multiple-choice questions. For those who wish, there is also space to make additional comments.

If you would like to participate in the survey, you can find it HERE.

The COVID-19 Clinical Research Coalition advocates and collaborates for the advancement of COVID-19 research that is driven by the needs of people in low-resource settings, and for equitable access to solutions in the global pandemic response.